Results showed a consistent benefit in both patients with and those without heart failure.
AHA 2015 Complete Coverage
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.
Physicians may need to ask young adults about energy drink intake in emergency settings.
Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.
Mortality rate is higher among women with heart disease after discharge from the hospital.
Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.
Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.
Many women in the United States do not feel personally connected to the risk of heart disease.
Personalized medications based on a patient's medical and biological profiles may be possible with 3D printing.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B
- April 28 Is Drug Take Back Day
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- ACP: Position Paper Recommends Solutions to Close Gender Equity Gap
- Vitamin D Insufficiency Associated With Insulin Resistance Independent of Obesity in Children
- Factors Identified to Predict Fatty Liver in Obese Teens